What is second nature to most marketers may not be well understood by healthcare professionals who have spent their careers as physicians, researchers, or caregivers.
Five things for pharma marketers to know: Tuesday, September 5, 2017
Merck CEO Kenneth Frazier’s exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.
Business analysts have generally agreed that WPP’s half-year earnings fell below expectations given recent market commentary, but have offered mixed guidance going forward.
Astellas promotes Moyra Knight to comms, corporate citizenship role
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
Five things for pharma marketers to know: Monday, July 31, 2017
FDA launches digital health pre-certification pilot; J&J’s experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Five things for pharma marketers to know: Thursday, July 27, 2017